At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 80 enrolled
Drug / intervention
Gabapentin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Gabapentin Premedication to Reduce Postoperative Nausea and Vomiting in Surgical Patient Receiving Spinal Morphine
In Brief
A Phase 4 clinical trial evaluating Gabapentin and Placebo for Postoperative Nausea and Vomiting. Completed, enrolled 80 participants across 1 site.
Detailed Summary
The intrathecal administration of morphine is gaining popularity. It is easy to do and can reduce the pain after surgery up to 24 hours. However, it causes postoperative nausea and vomiting more than other methods providing postoperative analgesia. Patients suffering from these side effects have to spend a longer period of time recovering in the hospital with high cost of medical treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Nausea and Vomiting
CountriesThailand
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartAug 2016
First PostedOct 2016
Primary CompletionFeb 2017
TodayJul 2026
First PostedOct 26, 2016
Enrollment StartAug 1, 2016
Primary CompletionFeb 1, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 9.7 years ago
Interventions
Gabapentindrug
Single oral dose
Placebodrug
Single oral dose